• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性无功能垂体腺瘤中人类Gαq关键残基(Arg183)的基因组序列分析

Genomic sequence analysis of a key residue (Arg183) in human G alpha q in invasive non-functional pituitary adenomas.

作者信息

Farrell W E, Talbot J A, Bicknell E J, Simpson D, Clayton R N

机构信息

Centre for Cell and Molecular Medicine, School of Post Graduate Medicine, University of Keele, Stoke-on-Trent, UK.

出版信息

Clin Endocrinol (Oxf). 1997 Aug;47(2):241-4. doi: 10.1046/j.1365-2265.1997.2891088.x.

DOI:10.1046/j.1365-2265.1997.2891088.x
PMID:9302401
Abstract

OBJECTIVE

With isolated exceptions the only oncogene significantly associated with pituitary tumours is a constitutively active Gs protein (G alpha s). The recent cloning of the cDNA of human G alpha q has facilitated the study of this activator of the phospholipase C beta/Ca2+/ protein kinase C pathway. Since, with isolated exceptions, non-functional tumours are responsive in vitro to TRH and GnRH which activate Gq, we have investigated the genomic sequence of G alpha q, in non-functional (NF) invasive pituitary adenomas, at a residue corresponding to the one most frequently mutated in G alpha s.

PATIENTS AND MEASUREMENTS

We studied 27 invasive NF pituitary tumours by direct sequencing of DNA derived from archival slide extracted tumour cells. Primers were designed to encompass Arg183 (corresponding to Arg201 of G alpha s) which when mutated has been shown to have oncogenic potential when transfected into cultural rat fibroblasts. In a previous study we have described allelic loss at tumour suppressor gene loci (TSG) in 7 of these 27 tumours.

RESULTS

We successfully amplified genomic DNA with primers designed from the cDNA sequence of G alpha q with specific exclusion of a processed pseudogene. No mutations were found at Arg183, in either the tumours showing allelic losses at specific TSG loci, or in the 20 remaining tumours in which we found no losses at the TSG loci investigated.

CONCLUSIONS

Mutations at this key residue in G alpha q occur infrequently, if at all, in invasive non-functional pituitary tumours. However we cannot exclude the possibility of mutation(s) at the other key residue of G alpha q, Gin209, implicated in GTP hydrolysis, or in other components of this pathway.

摘要

目的

除个别例外,唯一与垂体肿瘤显著相关的癌基因是组成型激活的Gs蛋白(Gαs)。人Gαq cDNA的近期克隆促进了对磷脂酶Cβ/ Ca2 + /蛋白激酶C途径激活剂的研究。由于除个别例外,无功能肿瘤在体外对激活Gq的促甲状腺激素释放激素(TRH)和促性腺激素释放激素(GnRH)有反应,我们研究了侵袭性无功能垂体腺瘤中Gαq的基因组序列,该序列对应于Gαs中最常发生突变的残基。

患者与测量

我们通过对存档玻片提取的肿瘤细胞DNA进行直接测序,研究了27例侵袭性无功能垂体肿瘤。设计引物以涵盖Arg183(对应于Gαs的Arg201),当该残基发生突变时,已证明将其转染到培养的大鼠成纤维细胞中具有致癌潜力。在先前的一项研究中,我们描述了这27例肿瘤中的7例肿瘤抑制基因位点(TSG)的等位基因缺失。

结果

我们成功地用根据Gαq cDNA序列设计的引物扩增了基因组DNA,特异性排除了一个加工过的假基因。在Arg183处未发现突变,无论是在特定TSG位点显示等位基因缺失的肿瘤中,还是在其余20例在研究的TSG位点未发现缺失的肿瘤中。

结论

在侵袭性无功能垂体肿瘤中,Gαq的这个关键残基即使发生突变也很少见。然而,我们不能排除Gαq的另一个关键残基Gln209(与GTP水解有关)或该途径其他成分发生突变的可能性。

相似文献

1
Genomic sequence analysis of a key residue (Arg183) in human G alpha q in invasive non-functional pituitary adenomas.侵袭性无功能垂体腺瘤中人类Gαq关键残基(Arg183)的基因组序列分析
Clin Endocrinol (Oxf). 1997 Aug;47(2):241-4. doi: 10.1046/j.1365-2265.1997.2891088.x.
2
Pituitary adenomas: screening for G alpha q mutations.垂体腺瘤:Gαq 基因突变筛查
J Clin Endocrinol Metab. 1997 Dec;82(12):4184-8. doi: 10.1210/jcem.82.12.4436.
3
Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes.
J Clin Endocrinol Metab. 1996 Mar;81(3):1134-40. doi: 10.1210/jcem.81.3.8772588.
4
Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours.临床无功能垂体瘤中的Gsα和Gi2α突变
Clin Endocrinol (Oxf). 1994 Dec;41(6):815-20. doi: 10.1111/j.1365-2265.1994.tb02798.x.
5
G protein mutations in tumours of the pituitary, parathyroid and endocrine pancreas.
Biochem Biophys Res Commun. 1995 Jun 26;211(3):1063-70. doi: 10.1006/bbrc.1995.1919.
6
Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.人垂体腺瘤中促甲状腺激素释放激素受体的结构
Clin Endocrinol (Oxf). 1996 Mar;44(3):341-7. doi: 10.1046/j.1365-2265.1996.684506.x.
7
G protein abnormalities in pituitary adenomas.垂体腺瘤中的G蛋白异常。
Mol Cell Endocrinol. 1998 Jul 25;142(1-2):1-14. doi: 10.1016/s0303-7207(98)00116-6.
8
p53 gene mutations in pituitary adenomas: rare events.垂体腺瘤中的p53基因突变:罕见事件。
Clin Endocrinol (Oxf). 1994 Dec;41(6):809-14. doi: 10.1111/j.1365-2265.1994.tb02797.x.
9
Analysis of a protein kinase C-alpha mutation in human pituitary tumours.人类垂体肿瘤中蛋白激酶C-α突变的分析
J Endocrinol. 1997 Apr;153(1):131-7. doi: 10.1677/joe.0.1530131.
10
GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.GTP酶抑制性突变激活Gs的α链并刺激人垂体肿瘤中的腺苷酸环化酶。
Nature. 1989 Aug 31;340(6236):692-6. doi: 10.1038/340692a0.

引用本文的文献

1
Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine.多组学整合分析揭示了在3P医学框架下人类无功能垂体神经内分泌肿瘤中的分子网络改变。
EPMA J. 2022 Feb 17;13(1):9-37. doi: 10.1007/s13167-022-00274-5. eCollection 2022 Mar.
2
Pituitary carcinoma with endolymphatic sac metastasis.垂体癌伴内淋巴囊转移。
Pituitary. 2014 Jun;17(3):210-3. doi: 10.1007/s11102-013-0489-x.
3
Pathogenesis of prolactinomas.催乳素瘤的发病机制。
Pituitary. 2005;8(1):7-15. doi: 10.1007/s11102-005-5080-7.
4
Malignant pituitary tumours.恶性垂体肿瘤。
Pituitary. 1998 Apr;1(1):69-81. doi: 10.1023/a:1009975009924.
5
Invasive pituitary adenomas: significance of proliferation parameters.侵袭性垂体腺瘤:增殖参数的意义
Pituitary. 1999 Aug;2(2):117-22. doi: 10.1023/a:1009931413106.